Mizuno K, Chretien B, Nishida K, Ito T, et al. Vonoprazan is associated with a phenotype-specific increase in cholangitis reporting in immune checkpoint inhibitor-treated patients: a VigiBase pharmacovigilance study. J Gastroenterol 2026 Jun 26. doi: 10.1007/s00535-026-02469.
PMID: 42362797